In case of persistent splenic enlargement or unexpected hematologic response during effective treatment of Ph+CML the possibility of an underlying JAK2 positive hematopoietic clone should always be entertained. The gene discussed is JAK2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.